Mack David Henry — SEC Form 4 filings
SEC reporting owner CIK 1341642. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-22 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 58,411 shares, $62,179 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 58,411 shares @ $1.06 ($62,179) in PMV Pharmaceuticals, Inc., filed 2025-07-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | President and CEO, Director | 7 | — | 1 leg · 58,411 sh · $62,179 | 15 |
Form 4 filings — Mack David Henry
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-09 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/award (A): 744,960 (derivative) @ $0 | EDGAR |
| 2025-10-29 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Option exercise (M): 220,643 @ $1.37 · Option exercise (M): 220,643 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Sale (S): 58,411 @ $1.06 | EDGAR |
| 2025-03-05 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Option exercise (M): 91,750 @ $0.53 · Option exercise (M): 17,709 @ $0.53 · Option exercise (M): 91,750 (derivative) @ $0 · Option exercise (M): 17,709 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Disposition to issuer (D): 134,584 (derivative) · Disposition to issuer (D): 249,600 (derivative) · Grant/award (A): 384,184 (derivative) · Disposition to issuer (D): 330,000 (derivative) · Grant/award (A): 330,000 (derivative) | EDGAR |
| 2024-01-22 | 4 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/award (A): 163,890 @ $0 · Grant/award (A): 519,915 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1341642 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →